TD Health Sciences Fund $16.09

TD HEALTH SCIENCES FUND $16.09 (CWA Rating: Speculative) (TD Asset Management, P.O. Box 7500, Station A, Toronto, Ontario. M5W 1P9. 1-800-463-3863; Web site: www.tdcanadatrust.ca. No load — deal directly with the bank) invests mostly in U.S. companies with a mixture of large-capitalization stocks and earlier-stage biotechnology shares. The fund’s managers believe all these firms will profit from an aging population stimulating higher spending by governments and individuals on health care, drugs and research. The fund’s top holdings include WellPoint, Amgen, Sepracor, ImClone Systems, Genentech, Gilead Sciences, UnitedHealth Group, Wyeth, Community Health Systems and Cephalon. Its MER is 2.79%. The $286.4 million fund’s manager is well-known U.S. fund manager T. Rowe Price Associates. TD Health Sciences gained 6.6% over the last year. TD Health Sciences Fund is still a buy.

A professional investment analyst for more than 30 years, Pat has developed a stock-selection technique that has proven reliable in both bull and bear markets. His proprietary ValuVesting System™ focuses on stocks that provide exceptional quality at relatively low prices. Many savvy investors and industry leaders consider it the most powerful stock-picking method ever created.